Biologics May Delay Arthritis in Psoriasis Patients Biologics May Delay Arthritis in Psoriasis Patients

Treatment with the interleukin-12/23 inhibitor ustekinumab or interleukin-23 inhibitors was linked to a lower risk of developing psoriatic arthritis compared with tumor necrosis factor inhibitors.MDedge News
Source: Medscape Dermatology Headlines - Category: Dermatology Tags: Rheumatology News Source Type: news